A comparison of the efficacy of ketotifen (HC 20‐511) with sodium cromoglycate (SCG) in skin test positive asthma.

19Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

1 Ketotifen (HC 20‐511 Sandoz) 1 mg twice daily for 12 weeks was found to be equivalent to sodium cromoglycate (SCG) 20 mg four times daily for 12 weeks in 35 skin test positive asthmatic patients in a randomised double‐blind cross‐over study. 2 No statistically significant difference between the two drugs in mean values for daily peak flow rates, diary card scores and spirometry at monthly visits was demonstrated. 3 Treatment failures as judged by severe asthma requiring withdrawal from the trial or addition of short courses of prednisone occurred in three patients on each drug. 4 Sedation was noted by 10 patients onHC 20‐511 and 5 on SCG. 5 Weight loss was noted in those patients on SCG, but not those on HC 20‐511. 1980 The British Pharmacological Society

Cite

CITATION STYLE

APA

Clarke, C., & May, C. (1980). A comparison of the efficacy of ketotifen (HC 20‐511) with sodium cromoglycate (SCG) in skin test positive asthma. British Journal of Clinical Pharmacology, 10(5), 473–476. https://doi.org/10.1111/j.1365-2125.1980.tb01791.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free